ArticleCardiovascular diabetology2023

Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis.

Peter Rossing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.